Visit us for CDMO-plus services
uBriGene Biosciences Inc. is a leading contract development and manufacturing organization (CDMO), specializing in development and application of cell and gene therapy technologies. uBriGene provides clients with end-to-end cell and gene therapy support and is committed to driving innovation in biologics development and accelerating cell and gene therapy process from concept to commercialization. By ensuring the highest quality of products and services, uBriGene's goal is to optimize time and cost efficiencies for its clients.
What We Provide
State-of-the-art GMP Facilities and High-Quality Services
The facilities provide six manufacturing platforms for plasmid production, viral vector manufacturing, cell products (CAR-T, CAR-NK, MSC and iPSC) manufacturing, QC release testing, process & assay development, and RNA drug substance and products.
Brands: We are a CDMO dedicated to acceleration of cell and gene therapy development from concept to commercialization.